Twist Bioscience Corp (NASDAQ: TWST)

Twist Bioscience Corporation (TWST) is a biotechnology company operating in the synthetic biology industry. Its primary business activities involve the design, synthesis, and manufacturing of synthetic DNA, RNA, and proteins for various applications, spanning healthcare, food and agriculture, industrial chemicals, and academic research.

The company generates revenue through its synthetic biology and next-generation sequencing (NGS) tools product lines, as well as biopharma services for antibody discovery, optimization, and development. Twist Bioscience's products are used in a wide range of applications, including drug discovery, disease detection, enzyme engineering, gene editing, and basic academic research.

Twist Bioscience's synthetic biology products cater to life sciences researchers across various healthcare applications. These include drug discovery, disease detection, enzyme engineering, gene editing, and basic academic research. The company's synthetic DNA allows researchers to design and manufacture synthetic genes, gene fragments, and oligonucleotides. The product range includes synthetic genes, gene fragments, oligo pools, and IgG proteins, primarily serving the healthcare industry.

In addition, Twist Bioscience's NGS tools play an integral role in the preparation of patient samples for sequencing. The company's products are used in diagnostic tests for various indications, including rare disease, SARS-CoV-2, and cancer through liquid biopsy. Twist Bioscience's NGS tools are also used in population genetics research, biomarker discovery, translational research, microbiology, and applied markets research, further expanding the company's reach within the healthcare sector.

Twist Bioscience's DNA synthesis platform is based on a proprietary technology that miniaturizes traditional chemical DNA synthesis reactions on silicon chips. This platform enables the company to achieve high levels of quality, precision, automation, and manufacturing throughput at a significantly lower cost than its competitors. This competitive advantage allows Twist Bioscience to offer high-quality products at a lower cost, making it an attractive partner for biopharma companies.

As a leading provider of synthetic DNA and DNA-based products, Twist Bioscience has established partnerships with prominent biopharma companies, such as Bayer, Boehringer Ingelheim, Takeda Pharmaceutical, and Astellas Pharma, among others. The company's strong presence in the synthetic biology and NGS markets further solidifies its position in the industry.

Twist Bioscience serves a global customer base of approximately 3,450 customers across various industries, including biotech, pharma, industrial chemicals, food and agriculture, and academic research. The diverse customer base includes leading biopharma companies, research institutions, and government agencies.